Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo.

The promoter of the human dihydrofolate reductase (DHFR) gene contains two consensus binding sites for the DNA binding protein Sp1. DNAse protection and gel mobility shift assays demonstrate binding of recombinant Sp1 to both decanucleotide Sp1 binding sequences which are located 49 and 14 base pair...

詳細記述

書誌詳細

出版年:	J Clin Invest
主要な著者:	Blume, S W, Snyder, R C, Ray, R, Thomas, S, Koller, C A, Miller, D M
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Clinical Investigation 1991
主題:	Research Article
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC295684/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1834700/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI115474
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!